Kazunobu Kato

Kazunobu Kato

UNVERIFIED PROFILE

Are you Kazunobu Kato?   Register this Author

Register author
Kazunobu Kato

Kazunobu Kato

Publications by authors named "Kazunobu Kato"

Are you Kazunobu Kato?   Register this Author

16Publications

697Reads

34Profile Views

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

J Clin Oncol 2018 05 27;36(14):1428-1439. Epub 2018 Mar 27.

Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Andreas Engert, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas Cancer Center, Humanitas University, Milan; Pier Luigi Zinzani, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy; John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Winship Cancer Institute, Emory University, Atlanta, GA; Jan Paul De Boer, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, on behalf of Lunenburg Lymphoma Phase I/II Consortium; John Kuruvilla, University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario; Kerry J. Savage, BC Cancer Agency, Vancouver, British Columbia, Canada; Marek Trneny, Charles University, General Hospital in Prague, Prague, Czech Republic; Kazunobu Kato, Anne Sumbul, and Benedetto Farsaci, Bristol-Myers Squibb, Princeton, NJ; and Stephen M. Ansell, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075855PMC
May 2018

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

J Clin Oncol 2018 04 2;36(10):942-950. Epub 2018 Feb 2.

Margaretha G.M. Roemer, Robert A. Redd, Fathima Zumla Cader, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Philippe Armand, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Geraldine S. Pinkus, Azra H. Ligon, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer, VU University Medical Center; Jan Paul De Boer, Antoni van Leeuwenhoek Hospital, Lunenburg Phase I/II Consortium, Amsterdam, the Netherlands; Stephanie Sasse, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas University, Rozzano, Milan; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; John Timmerman, University of California, Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Emory University, Atlanta, GA; John Kuruvilla, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Kerry J. Savage, British Columbia Cancer Agency Center for Lymphoid Cancer, Vancouver, British Columbia, Canada; Marek Trneny, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic; Stephen Ansell, Mayo Clinic, Rochester, MN; and Kazunobu Kato, Benedetto Farsaci, and Anne Sumbul, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877802PMC
April 2018

Dosing algorithm revisit for busulfan following IV infusion.

Cancer Chemother Pharmacol 2015 Mar 6;75(3):505-12. Epub 2015 Jan 6.

Otsuka Pharmaceutical Development and Commercialization, Inc., 506 Carnegie Center Drive, Princeton, NJ, 08540, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2660-0DOI Listing
March 2015

Nitration of tyrosine residues 368 and 345 in the beta-subunit elicits FoF1-ATPase activity loss.

Biochem J 2009 Sep 25;423(2):219-31. Epub 2009 Sep 25.

Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BJ20090594DOI Listing
September 2009

Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology.

Am J Physiol Cell Physiol 2006 Dec 2;291(6):C1225-31. Epub 2006 Aug 2.

University of California, Department of Molecular Biosciences, Davis, California 95616.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpcell.00307.2006DOI Listing
December 2006

Critical overview of mitochondrial nitric-oxide synthase.

Front Biosci 2006 Sep 1;11:2725-38. Epub 2006 Sep 1.

Department of Molecular Biosciences, University of California, School of Veterinary Medicine, Davis, CA 95616, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/2002DOI Listing
September 2006

Genetic deletion of mouse platelet glycoprotein Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size.

Blood 2004 Oct 22;104(8):2339-44. Epub 2004 Jun 22.

University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-03-1127DOI Listing
October 2004

Convulxin binds to native, human glycoprotein Ib alpha.

J Biol Chem 2003 Oct 24;278(41):39452-60. Epub 2003 Jul 24.

Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M300199200
Publisher Site
http://dx.doi.org/10.1074/jbc.M300199200DOI Listing
October 2003

The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion.

Blood 2003 Sep 8;102(5):1701-7. Epub 2003 May 8.

Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2003-03-07
Publisher Site
http://dx.doi.org/10.1182/blood-2003-03-0717DOI Listing
September 2003

A prototypic platelet septin and its participation in secretion.

Proc Natl Acad Sci U S A 2002 Mar;99(5):3064-9

Division of Experimental Hemostasis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.052715199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC122473PMC
March 2002